10/19/2026
FDA seeks input on ibogaine trial design, advances psychedelic framework
FDA's request for ibogaine trial input marks a step in psychedelic drug regulation.
Topic archive
psychoactive alkaloid
13 stories
10/10/2026
Ibogaine clinic appoints Tania Gonzalez as lead therapist
Gonzalez to enhance Jungian assessments and spearhead clinical research.
10/1/2026
Gabon seeks fair share from ibogaine boom
New decree aims to ensure benefit sharing from ibogaine's global trade.
9/28/2026
Psyence BioMed secures exclusive U.S. ibogaine license
Texas Ibogaine Research Corporation to lead U.S. ibogaine drug development.
9/28/2026
Psyence secures exclusive U.S. ibogaine license
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Psyence BioMed invests $5M in PsyLabs for U.S. ibogaine program
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/22/2026
Ibogaine program launches immersive Riviera Maya journey
New extended treatment integrates ibogaine therapy with cultural exploration.
9/22/2026
Ibogaine: Substance used by Presley Gerber for addiction
Ibogaine, a psychoactive alkaloid, is explored for addiction treatment.
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/6/2026
Ibogaine ceremony death leads to charges in Canada
Mississauga man charged after fatal ibogaine ceremony in Waterloo Region.